ClinicalTrials.Veeva

Menu

Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

Hypogonadism; Ovarian

Treatments

Diagnostic Test: Testosterone

Study type

Observational

Funder types

Other

Identifiers

NCT04760574
202010105RIND

Details and patient eligibility

About

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population

Full description

In this study, we conduct a cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population. Age-matched non-HIV infected MSM group will be used as comparison group. We will also determine the risk factors associated with male hypogonadism (age, duration of HIV infection, comorbidities, BMI, ART use). Correlation will be made between serum testosterone levels and sexual function, vitality, exercise capacity, mood, and bone mineral density.

Enrollment

1,200 estimated patients

Sex

Male

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • HIV-infected men who have sex with men
  • HIV non-infected men

Exclusion criteria

  • Use of testosterone supplement, anabolic steroid in the past one year.
  • History of pituitary , adrenal or gonad diseases
  • History of pituitary surgery or radiation therapy
  • History of systemic chemotherapy
  • Active opportunistic infection under treatment
  • Cancer
  • Severe hepatic, renal or cardiac impairment

Trial design

1,200 participants in 2 patient groups

Case group
Description:
HIV infected men who have sex with men
Treatment:
Diagnostic Test: Testosterone
Control group
Description:
HIV non-infected men
Treatment:
Diagnostic Test: Testosterone

Trial contacts and locations

1

Loading...

Central trial contact

Shyang-Rong Shih, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems